BR112022026509A2 - Métodos para diagnosticar patógenos respiratórios e prever resultados relacionados à covid-19 - Google Patents
Métodos para diagnosticar patógenos respiratórios e prever resultados relacionados à covid-19Info
- Publication number
- BR112022026509A2 BR112022026509A2 BR112022026509A BR112022026509A BR112022026509A2 BR 112022026509 A2 BR112022026509 A2 BR 112022026509A2 BR 112022026509 A BR112022026509 A BR 112022026509A BR 112022026509 A BR112022026509 A BR 112022026509A BR 112022026509 A2 BR112022026509 A2 BR 112022026509A2
- Authority
- BR
- Brazil
- Prior art keywords
- covid
- methods
- respiratory pathogens
- predict
- diagnose respiratory
- Prior art date
Links
- 208000025721 COVID-19 Diseases 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 244000052769 pathogen Species 0.000 title abstract 3
- 230000000241 respiratory effect Effects 0.000 title abstract 3
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 abstract 1
- 241001678559 COVID-19 virus Species 0.000 abstract 1
- 208000011380 COVID-19–associated multisystem inflammatory syndrome in children Diseases 0.000 abstract 1
- 230000007067 DNA methylation Effects 0.000 abstract 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 abstract 1
- 208000037847 SARS-CoV-2-infection Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 abstract 1
- 238000010801 machine learning Methods 0.000 abstract 1
- 208000024353 multisystem inflammatory syndrome in children Diseases 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063042669P | 2020-06-23 | 2020-06-23 | |
| PCT/US2021/038763 WO2021262894A1 (en) | 2020-06-23 | 2021-06-23 | Methods for diagnosing respiratory pathogens and predicting covid-19 related outcomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022026509A2 true BR112022026509A2 (pt) | 2023-03-07 |
Family
ID=79281779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022026509A BR112022026509A2 (pt) | 2020-06-23 | 2021-06-23 | Métodos para diagnosticar patógenos respiratórios e prever resultados relacionados à covid-19 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240093318A1 (enExample) |
| EP (1) | EP4168593A4 (enExample) |
| JP (1) | JP2023532444A (enExample) |
| KR (1) | KR20230038486A (enExample) |
| CN (1) | CN116096920A (enExample) |
| AU (1) | AU2021297245A1 (enExample) |
| BR (1) | BR112022026509A2 (enExample) |
| CA (1) | CA3184128A1 (enExample) |
| MX (1) | MX2023000105A (enExample) |
| WO (1) | WO2021262894A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4308017A4 (en) * | 2021-03-18 | 2025-02-12 | The Board of Trustees of the Leland Stanford Junior University | Systems and methods to generate a surgical risk score and uses thereof |
| EP4303326A1 (fr) * | 2022-07-06 | 2024-01-10 | Biomérieux | Determination du risque de deces d'un sujet infecte par un virus respiratoire par mesure du niveau d'expression du gene oas2 |
| WO2024008955A1 (en) * | 2022-07-08 | 2024-01-11 | Age Labs As | Method of screening for severe covid-19 susceptibility |
| EP4484575A1 (de) * | 2023-06-30 | 2025-01-01 | Cerascreen GmbH | Markersequenzen zur diagnose und therapiesteuerung von patienten mit testosteron-defizienz |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US8114414B2 (en) | 1994-11-08 | 2012-02-14 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of cervical cancer |
| EP2298900A1 (en) | 1996-09-17 | 2011-03-23 | Novartis Vaccines and Diagnostics, Inc. | Compositions and methods for treating intracellular diseases |
| US6099848A (en) | 1997-11-18 | 2000-08-08 | The Trustees Of The University Of Pennsylvania | Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use |
| GB9726555D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Vaccine |
| WO2001041782A2 (en) | 1999-12-09 | 2001-06-14 | Chiron Corporation | Method for administering a cytokine to the central nervous system and the lymphatic system |
| US6855320B2 (en) | 2000-03-29 | 2005-02-15 | The Trustees Of The University Of Pennsylvania | Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity |
| AU2001255196A1 (en) | 2000-03-29 | 2001-10-08 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing immunogenicity of antigens |
| WO2002002807A2 (en) * | 2000-06-30 | 2002-01-10 | Epigenomics Ag | Diagnosis of diseases associated with cell signalling |
| US8771702B2 (en) | 2001-03-26 | 2014-07-08 | The Trustees Of The University Of Pennsylvania | Non-hemolytic LLO fusion proteins and methods of utilizing same |
| US7794728B2 (en) | 2002-05-29 | 2010-09-14 | The Regents Of The University Of California | Attenuated Listeria spp. and methods for using the same |
| US8337861B2 (en) | 2003-01-09 | 2012-12-25 | The Trustees Of The University Of Pennsylvania | Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| KR101192652B1 (ko) | 2003-02-06 | 2012-10-19 | 앤저 테라퓨틱스 인코퍼레이티드 | 비포식 세포로의 침투가 약화된 리스테리아, 리스테리아를 포함하는 백신, 및 그것의 사용방법 |
| US7935804B2 (en) | 2006-03-01 | 2011-05-03 | Aduro Biotech | Engineered Listeria and methods of use thereof |
| US7665238B2 (en) | 2006-04-03 | 2010-02-23 | S.C. Johnson & Son, Inc. | Air freshener with holder |
| CN101755044B (zh) | 2007-05-18 | 2014-06-11 | 米迪缪尼有限公司 | 通过冻干泡沫保存生物活性材料 |
| JP5985397B2 (ja) | 2009-11-11 | 2016-09-06 | アドバクシス インコーポレイテッド | 組換えリステリア株およびそれを含む免疫原性組成物 |
| EP2521797A4 (en) * | 2010-01-04 | 2013-07-10 | Lineagen Inc | DNA METHYLATION BIOMARKER FOR LUNG FUNCTION |
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| SG10201700916SA (en) | 2012-12-27 | 2017-03-30 | Aduro Biotech Inc | Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof |
| CA2955612C (en) | 2014-07-18 | 2022-05-17 | Advaxis, Inc. | Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer |
| EP3169355A4 (en) | 2014-07-18 | 2018-07-25 | Advaxis, Inc. | Listeria-based immunogenic compositions for eliciting anti-tumor responses |
| MA41218A (fr) | 2014-12-19 | 2017-10-24 | Advaxis Inc | Combinaison de vaccin à base de listeria comportant des anticorps anti-ox40 ou anti-gitr |
| BR112019018272A2 (pt) * | 2017-03-02 | 2020-07-28 | Youhealth Oncotech, Limited | marcadores metilação para diagnosticar hepatocelular carcinoma e câncer |
| MA47821A (fr) * | 2017-03-10 | 2020-01-15 | Self Screen Bv | Classificateur de méthylation pour la détection de cancers invasifs induits par le hpv, de cancers gynécologiques et anogénitaux non induits par le hpv et de leurs lésions précurseurs de haut grade |
-
2021
- 2021-06-23 EP EP21828082.4A patent/EP4168593A4/en active Pending
- 2021-06-23 AU AU2021297245A patent/AU2021297245A1/en active Pending
- 2021-06-23 KR KR1020237001814A patent/KR20230038486A/ko active Pending
- 2021-06-23 CA CA3184128A patent/CA3184128A1/en active Pending
- 2021-06-23 JP JP2022579814A patent/JP2023532444A/ja active Pending
- 2021-06-23 US US18/002,979 patent/US20240093318A1/en active Pending
- 2021-06-23 CN CN202180044432.0A patent/CN116096920A/zh active Pending
- 2021-06-23 BR BR112022026509A patent/BR112022026509A2/pt unknown
- 2021-06-23 MX MX2023000105A patent/MX2023000105A/es unknown
- 2021-06-23 WO PCT/US2021/038763 patent/WO2021262894A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20240093318A1 (en) | 2024-03-21 |
| MX2023000105A (es) | 2023-04-25 |
| AU2021297245A1 (en) | 2023-02-02 |
| EP4168593A1 (en) | 2023-04-26 |
| WO2021262894A1 (en) | 2021-12-30 |
| JP2023532444A (ja) | 2023-07-28 |
| EP4168593A4 (en) | 2024-11-27 |
| KR20230038486A (ko) | 2023-03-20 |
| CN116096920A (zh) | 2023-05-09 |
| CA3184128A1 (en) | 2021-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022026509A2 (pt) | Métodos para diagnosticar patógenos respiratórios e prever resultados relacionados à covid-19 | |
| BR112018075288A2 (pt) | métodos para diagnóstico de infecções bacterianas e virais | |
| MX2019002093A (es) | Métodos para la detección de cambios de copia genómica en muestras de adn. | |
| BR112016002637A2 (pt) | sincronização de barreira com cálculo dinâmico de largura | |
| BR112015005422A2 (pt) | folha de vidro e dispositivo que inclui a referida folha de vidro | |
| MX382410B (es) | Determinación de niveles de glicosaminoglicanos mediante espectrometría de masas. | |
| BR112023001942A2 (pt) | Citocinas inflamatórias e fadiga em indivíduo com doença mediada por complemento | |
| BR112015018696A2 (pt) | rotulagem de padrão | |
| BR112017023887A2 (pt) | banda de rodagem que compreende um bloco que apresenta uma pluralidade de cortes | |
| BR112015004775A2 (pt) | vacina de shigella viva atenuada, cepa de shigella mutada e vetor plasmídeo recombinante com base em um plasmídeo de invasão de shigella mutado | |
| Zhang et al. | Time series analysis of correlativity between pulmonary tuberculosis and seasonal meteorological factors based on theory of Human-Environmental Inter Relation | |
| MX2017012758A (es) | Metodo y aparato para estimar la cantidad de microorganismos en una unidad taxonomica en una muestra. | |
| CO2018001917A2 (es) | Método de detección de virus causante de enfermedades respiratorias por virus respiratorio sincitial y metapneumovirus humano | |
| Campins et al. | Serological survey of mumps immunity among health care workers in the Catalonia region of Spain | |
| EP4377876A4 (en) | Physical voting ballot with individual and unique numbering/coding | |
| BR112022019112A2 (pt) | Métodos e tratamento envolvendo excesso de light livre | |
| Benítez et al. | Pathogenesis and environmental factors in ventilator-associated pneumonia | |
| PAN et al. | Depressive symptoms and related factors among HIV-positive men who have sex with men in Shanghai | |
| Sadeghniiat et al. | Prevalence of work-related asthma among adult asthmatics referred to pulmonary clinics | |
| LU et al. | Clinical value of ABCD3-I score in the prediction of early stroke risk in patients with transient ischemic attack | |
| Chávez et al. | Conflict Resolution Mechanism, a tool for building access to justice | |
| XU | Role of microalbuminuria in the elderly with atherosclerosis | |
| Ferreira et al. | Uso de terapia antirretroviral em pessoas vivendo com HIV/AIDS: implicações para segurança do paciente | |
| LI et al. | On the correlation between different stages of non-small cell lung cancer with Treg cells and cytokines | |
| BR112013005495A2 (pt) | método e aparelho para processamento de entradas de sensor |